Nucleus Genomics Stock

Provides comprehensive DNA testing and analysis to assess health risks by combining genetic data with other medical factors for personalized insights.

Buy

Buy Nucleus Genomics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Nucleus Genomics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Overview

Nucleus Genomics offers a whole-genome DNA test that analyzes genetic variants to assess risks for various health conditions, including cancers, heart disease, and mental health disorders. The test uses advanced genetic models and insights from established genetics associations to provide accurate health risk information. Additionally, the company incorporates non-genetic factors, such as blood pressure and cholesterol levels, to refine its assessments.

Sector

Healthcare & Life Sciences

Founded

2021

Headquarters

New York, NY

Buy

Buy Nucleus Genomics shares

Sign up to view historical trading trends and place an offer.

Sell

Sell Nucleus Genomics shares

Understand share pricing, list anonymously, and benefit from transparent fees.

Nucleus Genomics Management Team

Nucleus Genomics people and management

  • Co-Founder, CEO
    Vikram Harpavat
  • Co-Founder
    George Church

Nucleus Genomics Valuations & Financials

Gain Insights Into Nucleus Genomics Stock Valuation & Share Prices

View real-time NPM data on Nucleus Genomics stock including daily Nucleus Genomics stock price estimates, valuation history, and historical share price information. Access Nucleus Genomics financing rounds, secondary trade levels, cap table data, and private company comparable transactions. Use NPM's private company valuation database to track Nucleus Genomics pricing across six independent market signals. Looking for private company due diligence data sources on Nucleus Genomics? Get in touch to learn more.

Similar Companies

Explore companies

like Nucleus Genomics

  • NuEyes Technologies

    Healthcare & Life Sciences

    Engineers augmented reality smart glasses to enhance visual capabilities for low-vision patients.

  • Affinia Therapeutics

    Healthcare & Life Sciences

    Develops next-generation gene therapies by designing novel AAV capsids to improve targeting, safety, and efficacy for serious diseases.

  • Proniras

    Healthcare & Life Sciences

    Develops novel small-molecule therapeutics for substance use and specialty CNS disorders targeting unmet medical needs.

  • CivicEye

    Healthcare & Life Sciences

    Delivers advanced cloud-based software that streamlines operations for law enforcement and public safety professionals.

  • Newomics

    Healthcare & Life Sciences

    Delivers microfluidic chips and multinozzle ionization platforms that enhance sample sensitivity and throughput for mass spectrometry workflows.

  • Springbuk

    Healthcare & Life Sciences

    Transforms medical data into insights to improve employee health and lower costs.

  • Cheerland

    Healthcare & Life Sciences

    Biologics contract development and manufacturing organization providing comprehensive CDMO services and developing large-scale production facilities.

  • Guaranteed

    Healthcare & Life Sciences

    Blends at-home care with advanced technology to provide personalized, compassionate end-of-life support for patients and their loved ones.

  • SigmaSense

    Healthcare & Life Sciences

    Supplies software-defined analog conversion architectures to optimize responsive interface controls and monitor advanced battery status.

FAQ

Questions?

We have answers

Buy Nucleus Genomics Stock

Nucleus Genomics stock does not trade on public stock exchanges. Nucleus Genomics stock is considered a private security and you need to be an accredited investor to trade shares. To invest in Nucleus Genomics stock you can either buy shares directly through the company or work with a secondary trading marketplace like Nasdaq Private Market.

Learn more about the secondary market for private company shares on the investors page.

Sell Nucleus Genomics Stock

Nucleus Genomics Stock does not trade on public stock exchanges. In order to sell Nucleus Genomics shares you need to work directly with the company or with a secondary trading marketplace like Nasdaq Private Market. NPM has more than a decade of experience helping sell shares on the private market to our network of institutional investors.

Learn more about NPM services for selling privately held stock on the Employee Shareholders page.

Read more about how to sell private company stock on the private secondary market:

 

Nucleus Genomics Stock Price

Nucleus Genomics does not have a publicly available stock price because it is privately held and not traded on public stock exchanges. Through the NPM Data and Intelligence database from Nasdaq Private Market, you can view Nucleus Genomics share price and other valuable private market data.

Read more about secondary market private company stock prices:

Nucleus Genomics Stock Ticker Symbol

There is no ticker symbol for Nucleus Genomics stock because it is a private company. Private companies do not have ticker symbols like public companies, they are identified primarily by using the company ‘street’ name or legal name.

Criteria to Sell Nucleus Genomics Stock

Nasdaq Private Market currently works with employees, ex-employees, and other company investors. In order to sell Nucleus Genomics stock you need to receive the company’s approval, which Nasdaq Private Market manages on your behalf.

Learn more about selling privately held stock on the Employee Shareholders page.

Read more about how to sell shares of a private company and eligibility for selling privately held stock:

 

Criteria to Buy or Invest in Nucleus Genomics Stock

Currently, Nasdaq Private Market only works with accredited entities and institutional investors to purchase private company stock. In order to invest in Nucleus Genomics stock, you need to be an accredited entity or institutional investor.

Learn more about the Nasdaq Private Market tool kit for investors on the Investor Trading page.

Nucleus Genomics Stock Settlement

Once you buy or sell, stock share ownership must transfer before funds are wired. With Nasdaq Private Market, clients leverage our patent-pending Transfer and Settlement technology which streamlines and manages transfer activity from match to settlement.

To learn more about private company stock Transfer and Settlement, check out the Transfer and Settlement page.

Nucleus Genomics IPO

Nucleus Genomics is a private company and has not had an IPO. There is currently no Nucleus Genomics IPO price. Get started to begin exploring the Nasdaq Private Market Data and Intelligence database and gain access to actionable data related to Nucleus Genomics IPO.

Learn more about Data and Intelligence private company stock data for institutional investors on the NPM Data and Intelligence Product Page.